JENNIFER O'DELL: Open Payments
NPI 1407610090 · OOLTEWAH, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,893 in 98 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $1,584 · 2025 $1,893
Food & beverage: $1,893
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $403 |
| ABBVIE INC. | 16 | $278 |
| Axsome Therapeutics, Inc. | 6 | $223 |
| Amgen Inc. | 11 | $207 |
| AstraZeneca Pharmaceuticals LP | 6 | $97 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $88 |
| PFIZER INC. | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $79 |
| Xeris Pharmaceuticals, Inc. | 3 | $69 |
| Exact Sciences Corporation | 3 | $53 |
Products named: Rybelsus, Auvelity, VRAYLAR, Ozempic, REPATHA, Kerendia, NURTEC ODT, CAPLYTA.
Industry payments across TN — which companies pay providers there.
